Novel strategies for the formulation and processing of poorly water-soluble drugs
K Göke, T Lorenz, A Repanas, F Schneider… - European Journal of …, 2018 - Elsevier
Low aqueous solubility of active pharmaceutical ingredients presents a serious challenge in
the development process of new drug products. This article provides an overview on some …
the development process of new drug products. This article provides an overview on some …
Solubility and dissolution profile assessment in drug discovery
K Sugano, A Okazaki, S Sugimoto… - Drug metabolism and …, 2007 - jstage.jst.go.jp
The purposes of the review are to: a) Provide a comprehensible introduction of the-state-
ofthe-art sciences of solubility and dissolution, b) introduce typical technologies to assess …
ofthe-art sciences of solubility and dissolution, b) introduce typical technologies to assess …
Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics
F Buyukozturk, JC Benneyan, RL Carrier - Journal of controlled release, 2010 - Elsevier
Lipid based drug delivery systems, and in particular self-emulsifying drug delivery systems
(SEDDS), show great potential for enhancing oral bioavailability but have not been broadly …
(SEDDS), show great potential for enhancing oral bioavailability but have not been broadly …
Biowaiver monographs for immediate release solid oral dosage forms: Diclofenac sodium and diclofenac potassium
B Chuasuwan, V Binjesoh, JE Polli, H Zhang… - Journal of …, 2009 - Elsevier
Literature data are reviewed regarding the scientific advisability of allowing a waiver of in
vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage …
vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage …
Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties
DM Mudie, N Samiei, DJ Marshall, GE Amidon… - The AAPS journal, 2020 - Springer
The rate and extent of drug dissolution in the gastrointestinal (GI) tract are highly dependent
upon drug physicochemical properties and GI fluid properties. Biorelevant dissolution media …
upon drug physicochemical properties and GI fluid properties. Biorelevant dissolution media …
Role of surfactant and pH on dissolution properties of fenofibrate and glipizide—a technical note
S Jamzad, R Fassihi - Aaps Pharmscitech, 2006 - Springer
Summary and Conclusions Depending on the dose size and solubility characteristics of low
solubility drugs, a meaningful and discriminatory power of dissolution rate testing can be …
solubility drugs, a meaningful and discriminatory power of dissolution rate testing can be …
Pulmonary drug delivery for acute respiratory distress syndrome
The acute respiratory distress syndrome (ARDS) is a life-threatening condition that causes
respiratory failure. Despite numerous clinical trials, there are no molecularly targeted …
respiratory failure. Despite numerous clinical trials, there are no molecularly targeted …
Design of multifunctional nanostructured lipid carriers enriched with α-tocopherol using vegetable oils
Vegetable oils are commonly used as components in many cosmetic products intended for
daily care due to their high beneficial and multifunctional effect on skin. The general …
daily care due to their high beneficial and multifunctional effect on skin. The general …
Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach
In this study the significant effect of chitosan on improving the dissolution rate and
bioavailability of aceclofenac has been demonstrated by simple solvent change method …
bioavailability of aceclofenac has been demonstrated by simple solvent change method …
A brief literature and patent review of nanosuspensions to a final drug product
WWL Chin, J Parmentier, M Widzinski, EH Tan… - Journal of …, 2014 - Elsevier
Particle size reduction can be used for enhancing the dissolution of poorly water-soluble
drugs in order to enhance bioavailability. In nanosuspensions, the particle size of the drug is …
drugs in order to enhance bioavailability. In nanosuspensions, the particle size of the drug is …